In the present study, we used a previously validated marker for senescent cell burden in humans, T‐cell expression of p16 mRNA levels (Liu et al. 2009), along with additional biomarkers of senescence, to compare the senescence phenotypes of control (lean) and T2DM participants. This evidence concerns the gene CDKN2A and type 2 diabetes mellitus.